N
Google TrendARSENAL (5000+) — Arsenal v Lille: Champions League – live
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:arsenal5000+anthony gordon500+montez sweat2000+rob lowe1000+tanner hudson500+frozen frenzy200+huevo1000+payton pritchard1000+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Benefit-risk assessment f" (30 stories)

Top Headline Story

Reported best practices for effective risk management of medical devices: a scoping review
Lead StoryFrontiersgeneral
Jun 9

Reported best practices for effective risk management of medical devices: a scoping review

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxQWWp1NHBSakZYRzhpZ1dKOElHdzNqWlBIdUM2NW5MYlJOLVNVT1djcUlFcDRsYjJSaGNabk11Y2hzenVUX254NVpiaXRMRTRnQlBWeGE1TUxNQzljOWRnS1JsamdYNlRSRXpfeUZwdE5Rc1lCVzF4eFIxaEtHSEhtdVdQTDI3NGp1NmlUd19sSG9ieW02TVgyMXBvbXU?oc=5" target="_blank">Reported best practices for effective risk management of medical devices: a scoping review</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
5000+18m ago

arsenal

Arsenal v Lille: Champions League – live

Filter stories
500+18m ago

anthony gordon

Anthony Gordon's first Barcelona goal, Manuel Neuer's mistake and Djed Spence's Inter debut in the Euro Debrief

Filter stories
2000+28m ago

montez sweat

Bears DE Montez Sweat suspended two games for violating NFL's PED policy

Filter stories
1000+38m ago

rob lowe

Ben Shapiro’s Star-Studded ‘Confession’ Film Includes James Franco, Rob Lowe And More

Filter stories

Search Results for "Benefit-risk assessment f"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Quantitative benefit-risk analysis for prophylactic vaccines in the context of FDAs benefit-risk framework
Naturegeneral

Quantitative benefit-risk analysis for prophylactic vaccines in the context of FDAs benefit-risk framework

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE42MUtibWV1N0xaaGwyM0dDZ1lPX2dfMkpCeGdoQ0hkaWd6NHhqLUJXazdSd0xDXzFqbjRMWVg1ZVhrQ2NvX09wQUNvY2dFRlMwZGRFSW84VnltTUZDYlBJ?oc=5" target="_blank">Quantitative benefit-risk analysis for prophylactic vaccines in the context of FDAs benefit-risk framework</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Quantifying Benefit-Risk Preferences for Heart Failure Devices: A Stated-Preference Study
American Heart Association Journalstech

Quantifying Benefit-Risk Preferences for Heart Failure Devices: A Stated-Preference Study

<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE9wUVd3Ukk4a2l1RUR0UkI5Yk40SnRzSkk3ak5SZWpiR0oxeTY1Q05XN0swcW02RXdBV3Exam5zV1dCX2VNMExQblBGU04waU9XWnlKYXdpUmxaRExMQmJwT2lRWWxpUjN5bEJ5ZGpiUWlCZl9CQlE?oc=5" target="_blank">Quantifying Benefit-Risk Preferences for Heart Failure Devices: A Stated-Preference Study</a>  <font color="#6f6f6f">American Heart Association Journals</font>

Read Full StoryMore like this
Feasibility Study: What It Is, Benefits, and Examples
Investopediageneral

Feasibility Study: What It Is, Benefits, and Examples

<a href="https://news.google.com/rss/articles/CBMiakFVX3lxTFBqdDJZd3lCMUpxS2E1by1PR3p6Z3R6cEVrMFIwZUotWmY4VnZMN3AxWTNsWW4yMHVfdXZuQkU2UWY5VTI2emhsTnJOYjFROUJBQ0lHUEZ4MDBXelVEckwyNHhQYUNGNkJmV0E?oc=5" target="_blank">Feasibility Study: What It Is, Benefits, and Examples</a>  <font color="#6f6f6f">Investopedia</font>

Read Full StoryMore like this
Proceedings: PET Drugs—A 2023 Workshop on Product Quality, Regulatory Submissions, Facility Inspections, and Benefit–Risk Considerations
Journal of Nuclear Medicinegeneral

Proceedings: PET Drugs—A 2023 Workshop on Product Quality, Regulatory Submissions, Facility Inspections, and Benefit–Risk Considerations

<a href="https://news.google.com/rss/articles/CBMiWEFVX3lxTFBJajdrMWtrdk9BNk5KRHhUb0l2VFUzakg1Sl9vclItLVh3VkZEVEd2SkdsMHBFQWJhaUhFVVI4aDJJTHQyNGZ5ZU8xNFhkVkt5ck1BRmRLR0o?oc=5" target="_blank">Proceedings: PET Drugs—A 2023 Workshop on Product Quality, Regulatory Submissions, Facility Inspections, and Benefit–Risk Considerations</a>  <font color="#6f6f6f">Journal of Nuclear Medicine</font>

Read Full StoryMore like this
Benefit–Risk Assessment, Communication, and Evaluation (BRACE) throughout the life cycle of therapeutic products: overall perspective and role of the pharmacoepidemiologist
Wiley Online Libraryworld

Benefit–Risk Assessment, Communication, and Evaluation (BRACE) throughout the life cycle of therapeutic products: overall perspective and role of the pharmacoepidemiologist

<a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTFBQaklfMGNDcW9fWDlXRExCZVFjUWdGT2dNcDJoSXE1bHpyMkVObGNJdVZ6NlBpVWMzWVJJTGFHQkZncVdfWGRmRUROdVZHQ3FKQndSMnZFZy1QNUNncGJMVHZ5WkRpeVpz?oc=5" target="_blank">Benefit–Risk Assessment, Communication, and Evaluation (BRACE) throughout the life cycle of therapeutic products: overall perspective and role of the pharmacoepidemiologist</a>  <font color="#6f6f6f">Wiley Online Library</font>

Read Full StoryMore like this
F-35 Joint Strike Fighter: More Actions Needed to Explain Cost Growth and Support Engine Modernization Decision
U.S. Government Accountability Office (.gov)tech

F-35 Joint Strike Fighter: More Actions Needed to Explain Cost Growth and Support Engine Modernization Decision

<a href="https://news.google.com/rss/articles/CBMiVEFVX3lxTE80a0FOTTU0UlBFMHlCbDBQWWlIaEN6M05pczQ2RUhncF96RmtheWRmUFVIUDQ1Yk5kT1JMeWxTTTJsbHZULU1BNnpKR1lsVFR4c3VJag?oc=5" target="_blank">F-35 Joint Strike Fighter: More Actions Needed to Explain Cost Growth and Support Engine Modernization Decision</a>  <font color="#6f6f6f">U.S. Government Accountability Office (.gov)</font>

Read Full StoryMore like this
EU MDR's Benefit-Risk Ratio: Making Your Clinical Evaluations Safety-Focused
Med Device Onlinegeneral

EU MDR's Benefit-Risk Ratio: Making Your Clinical Evaluations Safety-Focused

<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxOSWllY01pZ1dmb1B6UkVORGxGaVlzN1NIR0wxaGc3VWlQY3BuS0tXTGZ1WmtKMTMyNVM2TGN2TElkYzNtUTlLMDhjTWxDRHdNcFJMaEhjVHlLVXc1czNYNTNEakJtUEtyQ0Z3N2doaV9OUWRtbFBQd1dWMm44Z2VvbFhOSE5sM200YzJVUVg3aHpUVUJTQ3l6STVUaDU0dmtKa3RhUExXNEF6TVNzQ1B3ZXRJbmJiZGs?oc=5" target="_blank">EU MDR's Benefit-Risk Ratio: Making Your Clinical Evaluations Safety-Focused</a>  <font color="#6f6f6f">Med Device Online</font>

Read Full StoryMore like this
Artificial intelligence for optimizing benefits and minimizing risks of pharmacological therapies: challenges and opportunities
Frontiersworld

Artificial intelligence for optimizing benefits and minimizing risks of pharmacological therapies: challenges and opportunities

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxPQXdodnBKeGlVUG9Xd3dPWVh0djRHTG9vS0tSYW05MVBOd205ZWVzQmY1X1FjY05FZlZvc1NMUWw2TlNUbWtCek1SSDc5V0JWRlpuYmdqNWRqUlJUQzd5RU1NMS1YZGZTRjQxN09uOTJ0cU5meDAyWmNGZHZ0VDRSbXVNTXpERWtsUVpoSmRDcmlpZnlqa3ZkaUtmTVZiLXp0ZWJJYmlnbw?oc=5" target="_blank">Artificial intelligence for optimizing benefits and minimizing risks of pharmacological therapies: challenges and opportunities</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
A framework for risk–benefit analysis of vaccines approved through accelerated pathways
Naturegeneral

A framework for risk–benefit analysis of vaccines approved through accelerated pathways

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9HNVdQbHBWMGpoeDEyb1EtMjJEV18wT2NEZFZUd3hpRzVQME1TMFJfbTAwaVVVTkxPZW43bldhZGlaTVg4T05valB4Q2YyUy1kaFAxWFctaXpnQmZMeVcw?oc=5" target="_blank">A framework for risk–benefit analysis of vaccines approved through accelerated pathways</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Toward comprehensive value assessment for Alzheimer's disease innovations
Wiley & Sonsgeneral

Toward comprehensive value assessment for Alzheimer's disease innovations

<a href="https://news.google.com/rss/articles/CBMidEFVX3lxTFBHSS1uT3NIVE5NcDlSUXpaZG1ld05nZmt0UTdtX3d1ZUJEUHBKWENpMC01UjNWOGVRdGNpWFByZEE0WHAwYW8tcVpRN0ZDVVdVNllvQUJnaGJPZHRtMU9wMzBKYTN1ZjMyZU05VTh6Ymd6RlpW?oc=5" target="_blank">Toward comprehensive value assessment for Alzheimer's disease innovations</a>  <font color="#6f6f6f">Wiley & Sons</font>

Read Full StoryMore like this
Assessing the benefit–risk of new treatments using generalised pairwise comparisons: the case of erlotinib in pancreatic cancer
Naturetech

Assessing the benefit–risk of new treatments using generalised pairwise comparisons: the case of erlotinib in pancreatic cancer

<a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTE1LdE9VRV9HUTNUOURFVXJVaXEzelpMV1JoTEpwYUgyNDUtWndZSVB2UHQ4WkUxdUc4M2hTV3lhS1piaXo2d1pMUENPZTZyd1NvWEJn?oc=5" target="_blank">Assessing the benefit–risk of new treatments using generalised pairwise comparisons: the case of erlotinib in pancreatic cancer</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Establishing patient safety monitoring in the benefit-risk paradigm for off-label and emergency use of medications for COVID-19: A pharmacovigilance perspective
Frontiersgeneral

Establishing patient safety monitoring in the benefit-risk paradigm for off-label and emergency use of medications for COVID-19: A pharmacovigilance perspective

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxOWW01OVZjZ3BHZXRpSWd1aVBaZkp3bE05N0VKVzJxeGRPU0NyQ1YwNHVRdzNBZC11enpUSlhEampBckMtNmlmNTY5ODdnejlualBTX24yTENoZGxJOS04TVlFUDZaczdhSTlJMVVmZ2VnSmxBai03YXNrTFlWMXAwWnZLV183dm5hRjg5bE9sajJueDh2UVQ2dFlHUnAxbWxCWjNDRklEcw?oc=5" target="_blank">Establishing patient safety monitoring in the benefit-risk paradigm for off-label and emergency use of medications for COVID-19: A pharmacovigilance perspective</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Strategy for communicating benefit-risk decisions: a comparison of regulatory agencies' publicly available documents
Frontierstech

Strategy for communicating benefit-risk decisions: a comparison of regulatory agencies' publicly available documents

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxPLTdvUDhRUGlkcVFCaUU1Q1ZxZENqMkNaZS1wRHJic18xWWVJanVVWVQwRW93OENEVDFORGVWM0JOSUxWcUc1bWNFM3JDS0lHLVQ0M19vUDl4Y2VRVmN6UVUydXBNTFJfbXpHQmhNWlNQVVJjZTBfUm5neWxuWGktb0ZKUDhPLUp3Q05ZckltN2VsQQ?oc=5" target="_blank">Strategy for communicating benefit-risk decisions: a comparison of regulatory agencies' publicly available documents</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Comprehensive evaluation of GLP-1 receptor agonists: an umbrella review of clinical outcomes across multiple diseases
Naturegeneral

Comprehensive evaluation of GLP-1 receptor agonists: an umbrella review of clinical outcomes across multiple diseases

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBocWdJdW1jUVhQUU5YUUxYOXZGQUZ0bWUzUWc5c1AzelA0clQ3UDloQWt0X2dlMGpWS2lyeUdWX2djUVIxYVRDRkpDYmZJUFJUWEJhNE9XUV8wMzBlVXQ4?oc=5" target="_blank">Comprehensive evaluation of GLP-1 receptor agonists: an umbrella review of clinical outcomes across multiple diseases</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
CORE-MD clinical risk score for regulatory evaluation of artificial intelligence-based medical device software
Naturetech

CORE-MD clinical risk score for regulatory evaluation of artificial intelligence-based medical device software

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFB5bS1QV3dFbE5vNXpnRFF6Z2dkaFB5bGRFVlY0cDc1aGpmV3ZQdTdUM3M1UXVDT0dsdmtXbl9xSEI5RWdLdk9VVUlRUEdXbW1fbXBNUkRPUHJMODRlNEhr?oc=5" target="_blank">CORE-MD clinical risk score for regulatory evaluation of artificial intelligence-based medical device software</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Probabilistic modelling is superior to deterministic approaches in the human health risk assessment: an example from a tribal stretch in central India
Naturescience

Probabilistic modelling is superior to deterministic approaches in the human health risk assessment: an example from a tribal stretch in central India

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFA0am1oQW9mcHZqTnRhbm9JSFRnSWRSbUxPb0dpX3dTZWNNaVVqdXdTOFdibHYxb0dRVU80a2o2ZjlpX3FWVFA1ZzFfVEZWQ2FLbmdIQmliYU1Edzh2UVhR?oc=5" target="_blank">Probabilistic modelling is superior to deterministic approaches in the human health risk assessment: an example from a tribal stretch in central India</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
An integrative framework for mapping the psychological landscape of risk perception
Naturegeneral

An integrative framework for mapping the psychological landscape of risk perception

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFA4UllYNFI3N2pPeUFkSEhmWm5ydThtZC1RSzVNVTVfXzEyN3g4Qnd1bUs3aE9xbXhzaDFaMW15LXhMZnpHMTNfRHBSSlpBWW9hT0xuM2VvdUFNakRld2R3?oc=5" target="_blank">An integrative framework for mapping the psychological landscape of risk perception</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Cost-effective adaptation strategies to rising river flood risk in Europe
Natureworld

Cost-effective adaptation strategies to rising river flood risk in Europe

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1kMVRkZ0lDYnk0cnl6UER1eUtJemhjYTAycUk4bnpYRzlRMVBqbE9fR2VlWU5zNGpJUjJuWUJ3bDlRTTJvOEJ4UEFELXJMamJCbWlFZXhqZG5abWo2SDBR?oc=5" target="_blank">Cost-effective adaptation strategies to rising river flood risk in Europe</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Beyond probability-impact matrices in project risk management: A quantitative methodology for risk prioritisation
Naturegeneral

Beyond probability-impact matrices in project risk management: A quantitative methodology for risk prioritisation

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1IcW5zcGYwdDhqV1A1VUZELXZhVXljdXRlYWtyZHpRUVBpZUd6aFlFSGlyRnJYMWJqVmpLUjVMN2plSXI2MFQtazVLZHdLQV9USHlYSUZKMk10ZDFqWE9N?oc=5" target="_blank">Beyond probability-impact matrices in project risk management: A quantitative methodology for risk prioritisation</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Weighing Benefits and Risks — The FDA's Review of Prasugrel
The New England Journal of Medicinegeneral

Weighing Benefits and Risks — The FDA's Review of Prasugrel

<a href="https://news.google.com/rss/articles/CBMiXkFVX3lxTFA3N0RTMUZIM3BiNDlJTUJaYUROTFNUdzh1V21wdi0xSm11U09Ca3RWM2FSdXc0bmJueG03QmRQeVRDMEhpZkJaNF9DaEFucHo2dTIxSExSRllfZ2hsYVE?oc=5" target="_blank">Weighing Benefits and Risks — The FDA's Review of Prasugrel</a>  <font color="#6f6f6f">The New England Journal of Medicine</font>

Read Full StoryMore like this
Belimumab or anifrolumab for systemic lupus erythematosus? A risk-benefit assessment
Frontiersgeneral

Belimumab or anifrolumab for systemic lupus erythematosus? A risk-benefit assessment

<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxQVHFSaW10UWZiS2J1NEJ4VG8yMXJOZXAzd0ZscC1ocHZ5NWZxaXJ4dTZsUWtzbFBPN2ZRRmlJWEVJaTFNRDEwaFFLODVUbk51T19JMVJ2d1YtRC1jZnN4eEVHeG1MQTBXRHIydkxVQ01pWlpqTk1QU3FJYURYSVd1N2Nrc01WU3RqOS1lbm9aQ3k?oc=5" target="_blank">Belimumab or anifrolumab for systemic lupus erythematosus? A risk-benefit assessment</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
A Benefit-Risk Assessment of Benzbromarone in the Treatment of Gout
Springer Nature Linkgeneral

A Benefit-Risk Assessment of Benzbromarone in the Treatment of Gout

<a href="https://news.google.com/rss/articles/CBMidEFVX3lxTFBiUFpVYnE2UU1nRklucHR2RzJrZXltTDhRbk1rWkVieWxvUEMySm01LWdYV2c5SUVUZ0ZoTEJpOFFlNkd2anNKNTl4VlNBb3hqcjNwMjhqWVpHZnp2VDBUN3BWNk9EM2tJUVhrd21MT3Q0SFd5?oc=5" target="_blank">A Benefit-Risk Assessment of Benzbromarone in the Treatment of Gout</a>  <font color="#6f6f6f">Springer Nature Link</font>

Read Full StoryMore like this
Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC
Naturegeneral

Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBZU0F1T0kzZDFOSnRNUlprYkhMUF9RSENzS0h4MTRDTDdQb3B5am9va19KcHlzdEU5cWFUMG9pdk9oaUUtMFZKSlFmOFZZSU1LSWZtcXh3U0Z2OGpMUmhr?oc=5" target="_blank">Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
AI risk management – A law and economics perspective
Cambridge University Press & Assessmenttech

AI risk management – A law and economics perspective

<a href="https://news.google.com/rss/articles/CBMiggJBVV95cUxQS1ZRbEtHekI1c3had3ZyUGxKUTh6Mi1SX2NMcDZYNEdrTzBKYzhJWTluYlhla0wyY1FzVHFDX1h1WGY2NEU2Mk5uRDhwUzBLamdzbl9NWXhQeGRBSVFFOFRaeUc4ajlXRzJYTFVzR29PWW50dlltc0cyTGQ0UzdEVjhSbmtudVBhZG5qcUQ1cGI4Q3RaVjUwUk9NcGoxR1NUWldxUnpFN3lHOWM1YWxGcEZBaVdRMzAxTHFJRFgzMkFpVk9oYmdjZC1QQldTZUM5SmEwSVZtQW1hc3cwRzU2RUluMXZ1MTVmdjhzZTQxX1JUUlhCVWkxQ0FtaGFVZUdKMUE?oc=5" target="_blank">AI risk management – A law and economics perspective</a>  <font color="#6f6f6f">Cambridge University Press & Assessment</font>

Read Full StoryMore like this
Benefit of systemic therapy in MINDACT patients with small, ER-positive, HER2-negative breast cancers
Naturegeneral

Benefit of systemic therapy in MINDACT patients with small, ER-positive, HER2-negative breast cancers

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE42UlZ2Rm9RVFVtZDhzUzFJTXRVTHg3dlMwa25EbzA1eHNvRklWQ3dqMkcwVmYxNndHSXQ1OEFNUVBLM3RiRDFyUHhFTWFxbGNCMk01YmR1X1VaN2Q0MDJR?oc=5" target="_blank">Benefit of systemic therapy in MINDACT patients with small, ER-positive, HER2-negative breast cancers</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
A Benefit-Risk Assessment of Caffeine as an Analgesic Adjuvant
Springer Nature Linkgeneral

A Benefit-Risk Assessment of Caffeine as an Analgesic Adjuvant

<a href="https://news.google.com/rss/articles/CBMidEFVX3lxTE5FeXk2TnNHOVdoNU9QZWRIZ2xQUGFHYnFHakV2bWNWNEpXUHg5R1M4RjE3NGk2TUpGM1lsUXVXTVE1dm9WeGJnRHVXREd4Y1phS2YwLW5BTVltSktNTFY1bUtnRkxIRXpOX0FPTmdNSzVGSWt6?oc=5" target="_blank">A Benefit-Risk Assessment of Caffeine as an Analgesic Adjuvant</a>  <font color="#6f6f6f">Springer Nature Link</font>

Read Full StoryMore like this
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
NEJMtech

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE9BYlBOYTFkcHpMMzhHblV2X3YxNURNdW1xOUlxdlhHODNlOGozVWY3RnF0QVE2ajlZSlN1SU9OTlMxanRVOFM5N0NlOXNDeXJPSUwtMklCTWxyRkVRZVZQOA?oc=5" target="_blank">70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer</a>  <font color="#6f6f6f">NEJM</font>

Read Full StoryMore like this
Pharmacovigilance and bioethics: the importance of a neglected relationship
Frontiersgeneral

Pharmacovigilance and bioethics: the importance of a neglected relationship

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxNc1FQMTNORG83dVlPX2dVVl90Vk9PUXotTGY0akpwQUJ5U3pQWHp6ejNGQmhMaTFzbFhBNUdQZVdZcWlNRWU1N1lIVlFmLVA1RVhhYmtnY21fMTVBSm1Va2Y3S09MS0YwUElTMHE0SExTY1dLbExrTktzNXJqOGg0bVJwbTM3SWhfaVlHWTZ4VWlDT0F4Q0VacjlQa3FxcXZRNk1LUWg4OA?oc=5" target="_blank">Pharmacovigilance and bioethics: the importance of a neglected relationship</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
18F-Fluoroestradiol PET/CT for Predicting Benefit from Endocrine Therapy in Patients with Estrogen Receptor–Positive Breast Cancer: A Systematic Review and Metaanalysis
Journal of Nuclear Medicinegeneral

18F-Fluoroestradiol PET/CT for Predicting Benefit from Endocrine Therapy in Patients with Estrogen Receptor–Positive Breast Cancer: A Systematic Review and Metaanalysis

<a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTFBTMGxiSlpXcEh4T2gxNzdRakdER2QzdDdCMkZSc3ZjNkdEdzhJd041THdmWmw3QVNRM0VmMGFBcnRKYnRVT05RdUJmVXVsSUI4ZXBCUUtDOA?oc=5" target="_blank">18F-Fluoroestradiol PET/CT for Predicting Benefit from Endocrine Therapy in Patients with Estrogen Receptor–Positive Breast Cancer: A Systematic Review and Metaanalysis</a>  <font color="#6f6f6f">Journal of Nuclear Medicine</font>

Read Full StoryMore like this
"Benefit-risk assessment f" — Live Google News Trends & Headlines